...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rock Stars still rocking it

Sarah did confirm that the cohorts are defined by dosage levels. I was hoping to gain something more specific that would give hints about the 3 stars and what other characteristics they may have that may begin to define them as a segment.

Hopefully good news will continue as time passes.

Toinv

Share
New Message
Please login to post a reply